Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / COM
-
Number of holders
-
193
-
Total 13F shares, excl. options
-
92.6M
-
Shares change
-
+7.18M
-
Total reported value, excl. options
-
$1.65B
-
Value change
-
+$118M
-
Put/Call ratio
-
1.58
-
Number of buys
-
120
-
Number of sells
-
-60
-
Price
-
$17.85
Significant Holders of Summit Therapeutics Inc. - COM (SMMT) as of Q4 2024
253 filings reported holding SMMT - Summit Therapeutics Inc. - COM as of Q4 2024.
Summit Therapeutics Inc. - COM (SMMT) has 193 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 92.6M shares
.
Largest 10 shareholders include BAKER BROS. ADVISORS LP (24.4M shares), VANGUARD GROUP INC (11.7M shares), BlackRock, Inc. (8.43M shares), FMR LLC (8.06M shares), PRICE T ROWE ASSOCIATES INC /MD/ (6.56M shares), STATE STREET CORP (5.6M shares), GEODE CAPITAL MANAGEMENT, LLC (3.2M shares), MILLENNIUM MANAGEMENT LLC (2.05M shares), CHARLES SCHWAB INVESTMENT MANAGEMENT INC (1.49M shares), and Pictet Asset Management Holding SA (1.39M shares).
This table shows the top 193 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.